I am cautious on this company. Revenue may not come in as fast as you believe. This type of screening is not the type of test running everyday. Running cost will be high with low volume. It only gives you a rough idea of possible infection and it needs to be further confirmed by other tests. It is not easy to sell this type of test.
US launch starting, page-12
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
67.5¢ |
Change
-0.015(2.17%) |
Mkt cap ! $155.4M | |||
| Open | High | Low | Value | Volume |
| 68.5¢ | 68.5¢ | 67.5¢ | $8.27K | 12.21K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34322 | 67.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 68.5¢ | 7757 | 1 |
View Market Depth
| Last trade - 13.57pm 29/11/2024 (20 minute delay) ? |
| GSS (ASX) Chart |
